Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Elliott M. Levy currently holds 51,700 shares of Omega Therapeutics, Inc. (OMGA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Elliott M. Levy has been a net neutral trader of OMGA stock. They have purchased $0 and sold $0 worth of shares.
Elliott M. Levy's most recent insider trade was on Jun 19, 2026, when they sold 23,811,896 shares at $0.00 per share.
Elliott M. Levy serves as Executive at Omega Therapeutics, Inc. (OMGA). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Elliott M. Levy holds the position of Executive at Omega Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Elliott M. Levy has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Elliott M. Levy was on Jun 19, 2026, when they sold $0 worth of NCNA shares. This transaction involved 23,811,896 shares at N/A per share.
Elliott M. Levy currently owns 51,700 shares of Omega Therapeutics, Inc. (OMGA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Elliott M. Levy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Elliott M. Levy has 4 Form 4 filings on record as an insider at Omega Therapeutics, Inc..
Set alerts for Elliott M. Levy and 40,000+ other insiders.